Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade and dexamethasone in relapsed Hodgkin's lymphoma
NCT00148018Phase 2Terminated
- Sponsor
- University of Cologne
- Start
- Mar 2005
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of bortezomib in Hodgkin lymphoma (HL), sponsored by University of Cologne. Primary endpoint: Overall Response Rate. Started Mar 2005; status: terminated.
02
Drugs
bortezomib
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00148018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148018.